BCLC Stage C Hepatocellular Carcinoma — Trials

BCLC Stage C Hepatocellular Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

21 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 5
Recruiting: 3
Ph III recruiting: 1
Growth YoY: —
Industry share: 20%
Top sponsor: City of Hope Medical Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (4)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04992143	TACE+Tilelizumab+Sorafenib in the Treatment of BCLC Stage C HCC	unknown	Phase 2	20	First Affiliated Hospital of Zhejiang UniversityOTHER	1	Feb 16, 2023	clinicaltrials
NCT04204577	The Safety and Efficacy of Thermal Ablation Combined With Apatinib and Carilimub for Advanced Liver Cancer	unknown	Phase 2	90	Chinese PLA General HospitalOTHER	1	Dec 19, 2019	clinicaltrials